Novavax Wins $1.6B From Feds To Make COVID-19 Vaccine
The U.S. government is pouring $1.6 billion into drugmaker Novavax Inc.'s efforts to develop a vaccine for COVID-19, the largest award yet under the Trump administration's campaign to fast-track treatments to...To view the full article, register now.
Already a subscriber? Click here to view full article